Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Expert Review of Anticancer Therapy
|
June 18, 2010
Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?
Vladimir Yutkin, Benjamin Nisman, Dov Pode
The Journal of Urology
|
October 20, 2007
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study
Vladimir Yutkin, Dov Pode, Eli Pikarsky, et al.
Urology
|
November 14, 2002
Primary and postoperative retroperitoneal fibrosis-experience with 18 cases
Ran Katz, Dragan Golijanin, Dov Pode, et al.
European Urology
|
August 8, 2009
Seminal vesicle cystadenoma: a rare clinical perspective
Gideon Lorber, Galina Pizov, Ofer N Gofrit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2010
Adenocarcinoma in an augmented bladder: result of a sequential dysplastic process
Shilo Rosenberg, Galina Pizov, Ofer N Gofrit, et al.
Anticancer Research
|
July 5, 2020
Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology
Vivian Barak, Dror Itzkovich, Roland Einarsson, et al.
Urology
|
September 3, 2013
A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications
Gideon Lorber, Shmuel Benenson, Shilo Rosenberg, et al.
European Urology
|
January 18, 2006
Watchful waiting policy in recurrent Ta G1 bladder tumors
Ofer N Gofrit, Dov Pode, Adi Lazar, et al.
Expert Opinion on Pharmacotherapy
|
April 18, 2015
Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options
Stavros Sfoungaristos, Ofer N Gofrit, Vladimir Yutkin, et al.
Urology
|
June 19, 2007
Significance of inflammatory pseudotumors in patients with a history of bladder cancer
Ofer N Gofrit, Dov Pode, Amos Shapiro, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Expert Review of Anticancer Therapy
|
June 18, 2010
Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?
Vladimir Yutkin, Benjamin Nisman, Dov Pode
The Journal of Urology
|
October 20, 2007
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study
Vladimir Yutkin, Dov Pode, Eli Pikarsky, et al.
Urology
|
November 14, 2002
Primary and postoperative retroperitoneal fibrosis-experience with 18 cases
Ran Katz, Dragan Golijanin, Dov Pode, et al.
European Urology
|
August 8, 2009
Seminal vesicle cystadenoma: a rare clinical perspective
Gideon Lorber, Galina Pizov, Ofer N Gofrit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2010
Adenocarcinoma in an augmented bladder: result of a sequential dysplastic process
Shilo Rosenberg, Galina Pizov, Ofer N Gofrit, et al.
Anticancer Research
|
July 5, 2020
Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology
Vivian Barak, Dror Itzkovich, Roland Einarsson, et al.
Urology
|
September 3, 2013
A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications
Gideon Lorber, Shmuel Benenson, Shilo Rosenberg, et al.
European Urology
|
January 18, 2006
Watchful waiting policy in recurrent Ta G1 bladder tumors
Ofer N Gofrit, Dov Pode, Adi Lazar, et al.
Expert Opinion on Pharmacotherapy
|
April 18, 2015
Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options
Stavros Sfoungaristos, Ofer N Gofrit, Vladimir Yutkin, et al.
Urology
|
June 19, 2007
Significance of inflammatory pseudotumors in patients with a history of bladder cancer
Ofer N Gofrit, Dov Pode, Amos Shapiro, et al.
Page
of 9